1-tert-Butyl 3-ethyl 3-cyanoazetidine-1,3-dicarboxylate, 95.0%, 1g

1-Isopropyl-1H-imidazole, 95.0%, 100g

2-Hexylthiophene>98.0%(GC)25g

5,6,7,8-Tetrahydro-4H-thiazolo[4,5-d]azepin-2-amine hydrobromide, 97%, 1g

2-(Trifluoromethyl)cinnamic acid, 95.0%, 10g

3-imidazo[1,2-a]pyridin-2-ylpropanoic acid hydrate, 95.0%, 5g

1-(1-Benzyl-1H-pyrazol-4-yl)-ethanone, 97%, 1g

N-Benzoyl-L-phenylalanine, 95.0%, 5g

2-(4-(Cyclopropanecarbonyl)phenyl)-2-methylpropanoic acid, 95+%, 500mg

GC capillary column ROTI®Cap-FFAP, 10 m, 0.10 mm, 0.10 µm, 1 Piece(s)

(2,4,6-Trichlorophenyl)hydrazine, 98.0%, 100g

tert-Butyl 3-oxo-2-azabicyclo[2.2.1]hept-5-ene-2-carboxylate, 95%, 250mg

2-((4-Chloro-2-nitrophenyl)amino)benzoic acid, 95.0%, 1g